Kimberly-Clark (NYSE:KMB) Price Target Raised to $152.00 at The Goldman Sachs Group

Kimberly-Clark (NYSE:KMB) had its price objective lifted by The Goldman Sachs Group from $135.00 to $152.00 in a research report report published on Wednesday, Benzinga reports. The Goldman Sachs Group currently has a buy rating on the stock.

KMB has been the subject of several other research reports. Barclays raised their price objective on shares of Kimberly-Clark from $124.00 to $132.00 and gave the company an equal weight rating in a research report on Friday, April 12th. Royal Bank of Canada restated a sector perform rating and issued a $123.00 price objective on shares of Kimberly-Clark in a research report on Thursday, March 28th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Kimberly-Clark from $127.00 to $132.00 and gave the company a hold rating in a research report on Thursday, March 28th. Piper Sandler raised their target price on shares of Kimberly-Clark from $145.00 to $152.00 and gave the company an overweight rating in a research note on Thursday, March 28th. Finally, HSBC raised their target price on shares of Kimberly-Clark from $134.00 to $146.00 and gave the company a hold rating in a research note on Thursday, March 28th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, Kimberly-Clark presently has an average rating of Hold and a consensus target price of $134.85.

Kimberly-Clark Trading Down 0.9 %

Shares of Kimberly-Clark stock opened at $135.24 on Wednesday. The stock has a market capitalization of $45.54 billion, a P/E ratio of 24.86, a price-to-earnings-growth ratio of 3.90 and a beta of 0.40. The company has a quick ratio of 0.54, a current ratio of 0.81 and a debt-to-equity ratio of 6.05. The company has a 50-day simple moving average of $125.86 and a 200 day simple moving average of $122.87. Kimberly-Clark has a 12-month low of $116.32 and a 12-month high of $147.09.

Kimberly-Clark (NYSE:KMB) last announced its earnings results on Tuesday, April 23rd. The company reported $2.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.61 by $0.40. The business had revenue of $5.15 billion during the quarter, compared to analysts’ expectations of $5.08 billion. Kimberly-Clark had a net margin of 9.05% and a return on equity of 250.28%. The firm’s revenue for the quarter was down .9% on a year-over-year basis. During the same quarter last year, the company posted $1.67 EPS. Research analysts expect that Kimberly-Clark will post 6.98 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Mark T. Smucker bought 827 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were acquired at an average cost of $120.98 per share, for a total transaction of $100,050.46. Following the completion of the acquisition, the director now owns 827 shares in the company, valued at $100,050.46. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, insider Paula Ramos sold 10,178 shares of the business’s stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $137.17, for a total transaction of $1,396,116.26. Following the transaction, the insider now directly owns 795 shares in the company, valued at $109,050.15. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Mark T. Smucker bought 827 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were purchased at an average price of $120.98 per share, for a total transaction of $100,050.46. Following the completion of the acquisition, the director now owns 827 shares of the company’s stock, valued at approximately $100,050.46. The disclosure for this purchase can be found here. 0.62% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Kimberly-Clark

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Rise Advisors LLC boosted its position in Kimberly-Clark by 926.3% during the first quarter. Rise Advisors LLC now owns 195 shares of the company’s stock worth $25,000 after purchasing an additional 176 shares during the period. Accordant Advisory Group Inc bought a new position in Kimberly-Clark during the first quarter worth $27,000. Cranbrook Wealth Management LLC boosted its position in Kimberly-Clark by 90.9% during the fourth quarter. Cranbrook Wealth Management LLC now owns 210 shares of the company’s stock worth $26,000 after purchasing an additional 100 shares during the period. OFI Invest Asset Management bought a new position in Kimberly-Clark during the third quarter worth $25,000. Finally, Centerpoint Advisors LLC boosted its position in Kimberly-Clark by 175.0% during the third quarter. Centerpoint Advisors LLC now owns 275 shares of the company’s stock worth $33,000 after purchasing an additional 175 shares during the period. 76.29% of the stock is owned by institutional investors.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.